![]() ![]() ![]() Entire stock of iron tablet to be withdrawn
MUMBAI:A Thane-based consumer has alerted the food and drug administration about iron pieces being found in a medically-prescribed iron tablet. The content of elemental iron in the tablet, prescribed for anaemia or lack of red blood cells, was way above permissible limits. FDA commissioner Mahesh Zagde has directed the Himachal Pradesh-based Galpha Laboratories to withdraw the entire stock of the product from Maharashtra. Simultaneously, the FDA has told 76,000-odd medical stores, public health and medical education departments not to prescribe the product. Read more ![]() 23rd-25th Feb NIPER, Raebareli to organise a symposium on 'medicinal chemistry & pharmaceutical sciences' in Lucknow
|
![]() National Consultation on Safe and Quality Healthcare organized by PSM India
![]() Hon’ble minister of Consumer Affairs, Govt. Of A.P., Shri.D .Shridhar Babu addressing the gathering
Doctor-Drugmaker deals: Will India follow suit ?
Drugmakers in the US will now have to make public any payment above $10 made to doctors, or invite heavy penalties. New federal guidelines make it mandatory for companies to disclose payments towards research, consulting, travel or entertainment.
![]() FIA, Punjab (Pak) government to jointly investigate fake drugs case
![]() ![]() Government sets up committee to regulate Internet-based drug trade
NEW DELHI: Even as a raging controversy brews over monitoring Internet content in the country, government has recently constituted a high-level committee to put in place "regulatory and legislative" measures to check online pharmacies trading in banned drugs. CDSCO plans to set up 20 mini labs at sea ports, airports
NEW DELHI: Even as the efforts to set up pharmaceutical zones at the main airports could not progress well in all places as planned, the Central Drugs Standard Control Organisation (CDSCO) has prepared a plan to set up at least 20 mini labs at sea ports and air ports.
|
![]() Pfizer recalls their Lo/Ovral®-28 and Norgestrel/Ethinyl Estradiol Tablets
NEW YORK: Pfizer Inc. announced today that it has voluntarily recalled 14 lots of Lo/Ovral®-28 (norgestrel and ethinyl estradiol)Tablets and 14 lots of Norgestrel and Ethinyl Estradiol Tablets (generic) for customers in the U.S. market. An investigation by Pfizer found that some blister packs may contain an inexact count of inert or active ingredient tablets and that the tablets may be out of sequence. The cause was identified and corrected immediately. 23 drugs declared as not-of-standard quality
|
|
![]() |